Hilary S. Connery

3.4k total citations · 1 hit paper
62 papers, 2.0k citations indexed

About

Hilary S. Connery is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Clinical Psychology. According to data from OpenAlex, Hilary S. Connery has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Public Health, Environmental and Occupational Health, 28 papers in Epidemiology and 16 papers in Clinical Psychology. Recurrent topics in Hilary S. Connery's work include Substance Abuse Treatment and Outcomes (27 papers), Opioid Use Disorder Treatment (27 papers) and Suicide and Self-Harm Studies (12 papers). Hilary S. Connery is often cited by papers focused on Substance Abuse Treatment and Outcomes (27 papers), Opioid Use Disorder Treatment (27 papers) and Suicide and Self-Harm Studies (12 papers). Hilary S. Connery collaborates with scholars based in United States, Australia and Russia. Hilary S. Connery's co-authors include Roger D. Weiss, R. Kathryn McHugh, Shelly F. Greenfield, Elena H. Chartoff, Margaret L. Griffin, Jennifer Sharpe Potter, Ian R. H. Rockett, Kathleen M. Carroll, Dorian R. Dodd and Garrett M. Fitzmaurice and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Hilary S. Connery

58 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medication-Assisted Treatment of Opioid Use Disorder

2015 410 citations Hilary S. Connery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hilary S. Connery United States	24	973	841	403	374	274	62	2.0k
Stacey C. Sigmon United States	32	1.5k 1.5×	1.3k 1.5×	495 1.2×	296 0.8×	218 0.8×	117	2.9k
Theresa Winhusen United States	28	764 0.8×	861 1.0×	477 1.2×	370 1.0×	484 1.8×	132	2.6k
Alex Baldacchino United Kingdom	25	651 0.7×	625 0.7×	279 0.7×	530 1.4×	253 0.9×	111	2.2k
Emily B. Einstein United States	18	752 0.8×	566 0.7×	312 0.8×	185 0.5×	337 1.2×	32	1.8k
Helge Waal Norway	26	1.2k 1.3×	985 1.2×	531 1.3×	206 0.6×	132 0.5×	91	1.9k
Jennifer Sharpe Potter United States	29	1.6k 1.6×	1.2k 1.4×	588 1.5×	471 1.3×	205 0.7×	91	3.0k
Bruna Brands Canada	22	655 0.7×	884 1.1×	280 0.7×	229 0.6×	267 1.0×	141	2.1k
Maureen Hillhouse United States	31	1.6k 1.6×	1.7k 2.0×	509 1.3×	379 1.0×	474 1.7×	71	3.0k
Sharlene Kaye Australia	32	813 0.8×	1.3k 1.5×	197 0.5×	581 1.6×	539 2.0×	80	3.0k
Linda Gowing Australia	29	1.3k 1.4×	1.5k 1.8×	475 1.2×	357 1.0×	408 1.5×	50	3.4k

Countries citing papers authored by Hilary S. Connery

Since Specialization

Citations

This map shows the geographic impact of Hilary S. Connery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary S. Connery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary S. Connery more than expected).

Fields of papers citing papers by Hilary S. Connery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilary S. Connery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary S. Connery. The network helps show where Hilary S. Connery may publish in the future.

Co-authorship network of co-authors of Hilary S. Connery

This figure shows the co-authorship network connecting the top 25 collaborators of Hilary S. Connery. A scholar is included among the top collaborators of Hilary S. Connery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilary S. Connery. Hilary S. Connery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rasimas, Joseph J., et al.. (2025). Understanding an overdose: intention, motivation, and risk. Clinical Toxicology. 63(2). 75–82.

Bateman, Brian T., Loreen Straub, Sonia Hernández–Dı́az, et al.. (2025). Buprenorphine and Methadone Discontinuation During Pregnancy and the Postpartum Period: A Nationwide Cohort Study. American Journal of Psychiatry. 182(12). 1060–1071.

Straub, Loreen, Brian T. Bateman, Sonia Hernández–Dı́az, et al.. (2024). Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone. JAMA. 332(10). 805–805. 5 indexed citations

Suarez, Elizabeth A., Krista F. Huybrechts, Loreen Straub, et al.. (2023). Buprenorphine Versus Methadone for Opioid Use Disorder in Pregnancy. Obstetrical & Gynecological Survey. 78(6). 325–327.

Suarez, Elizabeth A., Krista F. Huybrechts, Loreen Straub, et al.. (2023). Postpartum Opioid-Related Mortality in Patients With Public Insurance. Obstetrics and Gynecology. 141(4). 657–665. 9 indexed citations

Rosenthal, Richard N., Justine W. Welsh, Hilary S. Connery, et al.. (2020). Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry. American Journal on Addictions. 29(5). 401–406. 1 indexed citations

Connery, Hilary S., Nadine R. Taghian, Jung‐Jin Kim, et al.. (2019). Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug and Alcohol Dependence. 205. 107612–107612. 47 indexed citations

Madras, Bertha K. & Hilary S. Connery. (2019). Psychiatry and the Opioid Overdose Crisis. FOCUS The Journal of Lifelong Learning in Psychiatry. 17(2). 128–133. 6 indexed citations

Rockett, Ian R. H., Eric D. Caine, Steven Stack, et al.. (2018). Method overtness, forensic autopsy, and the evidentiary suicide note: A multilevel National Violent Death Reporting System analysis. PLoS ONE. 13(5). e0197805–e0197805. 36 indexed citations

10.

Miller, Ann C., Shelly F. Greenfield, G. V. Yanova, et al.. (2016). Understanding HIV Risk Behavior among Tuberculosis Patients with Alcohol Use Disorders in Tomsk, Russian Federation. PLoS ONE. 11(2). e0148910–e0148910. 5 indexed citations

11.

McHugh, R. Kathryn, et al.. (2016). Predictors of early dropout in outpatient buprenorphine/naloxone treatment. American Journal on Addictions. 25(6). 472–477. 65 indexed citations

12.

DeVido, Jeffrey, Hilary S. Connery, & Kevin P. Hill. (2015). Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series. Journal of Opioid Management. 11(4). 363–366. 11 indexed citations

13.

Suzuki, Joji, et al.. (2015). Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Academic Psychiatry. 40(3). 498–502. 13 indexed citations

14.

Shin, Sonya, Hilary S. Connery, Alan L. Shields, et al.. (2013). Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction. 108(8). 1387–1396. 28 indexed citations

15.

Schuman‐Olivier, Zev, Hilary S. Connery, Margaret L. Griffin, et al.. (2013). Clinician beliefs and attitudes about buprenorphine/naloxone diversion. American Journal on Addictions. 22(6). 574–580. 32 indexed citations

16.

Shin, Sonya, Trini Mathew, G. V. Yanova, et al.. (2010). Alcohol Consumption among Men and Women with Tuberculosis in Tomsk, Russia. Central European Journal of Public Health. 18(3). 132–138. 21 indexed citations

17.

Mathew, Trini, Alan L. Shields, А. К. Стрелис, et al.. (2010). Performance of the Alcohol Use Disorders Identification Test Among Tuberculosis Patients in Russia. Substance Use & Misuse. 45(4). 598–612. 18 indexed citations

18.

Meade, Christina S., Roger D. Weiss, Garrett M. Fitzmaurice, et al.. (2010). HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results From a NIDA Clinical Trials Network Multisite Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 65–72. 26 indexed citations

19.

Trucco, Elisa M., Hilary S. Connery, Margaret L. Griffin, & Shelly F. Greenfield. (2007). The Relationship of Self‐Esteem and Self‐Efficacy to Treatment Outcomes of Alcohol‐Dependent Men and Women. American Journal on Addictions. 16(2). 85–92. 30 indexed citations

20.

Kleber, Herbert D., Roger D. Weiss, Raymond F. Anton, et al.. (2006). Treatment of patients with substance use disorders. American Journal of Psychiatry. 163. 1–275. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact